New therapeutic avenues in ulcerative colitis: thinking out of the box.
about
Current stage in inflammatory bowel disease: What is next?Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies.The impact of ATRA on shaping human myeloid cell responses to epithelial cell-derived stimuli and on T-lymphocyte polarizationLong-Term Effects of Bone Marrow-Derived Mesenchymal Stem Cells in Dextran Sulfate Sodium-Induced Murine Chronic ColitisUrsodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.Pathway-based approaches to the treatment of inflammatory bowel disease.Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial.Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity.Carnosic acid prevents dextran sulfate sodium-induced acute colitis associated with the regulation of the Keap1/Nrf2 pathway.Advancing the science and practice of gastroenterology and hepatologyHuman filarial proteins attenuate chronic colitis in an experimental mouse model.Accumulation of HLA-DR4 in Colonic Epithelial Cells Causes Severe Colitis in Homozygous HLA-DR4 Transgenic Mice.Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.Role of DDX3 in the pathogenesis of inflammatory bowel disease.miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques.Endoplasmic reticulum stress-induced apoptosis in intestinal epithelial cells: a feed-back regulation by mechanistic target of rapamycin complex 1 (mTORC1).
P2860
Q26777429-F592A5E4-03BD-4E42-BC56-238A1D095345Q34499080-EEA243B6-CCE0-4994-9466-AE09FAF37E01Q34507117-06D1F9EA-D9DD-4205-8EE8-BFE36B101E03Q34786166-66725DE5-784C-4E07-AE3D-2D49ADA87FCEQ35508697-DFD51B42-C6A6-4D9C-B24A-FA7D7D6EBDDAQ36848955-63662811-46E7-4C5B-A9A9-9350109A8C25Q38288518-4FB408FC-FCBC-474D-B904-D3C31A844781Q38593257-842C96CC-1BB0-4C19-A080-C8EABBFF1924Q40085244-01A7F980-4DC0-4982-B327-5A0785B66A2EQ41127262-3FA0BB7C-394F-46C5-8A13-E41D22B34AF9Q41477958-B66ABFB3-BDA9-4E40-A6AF-B3BE4D0AFCEBQ41774264-F4A97F81-067A-4D82-88D7-5D6846382B8CQ47266007-4AC647DA-D546-4EAF-AEB0-DBC2D59C0DC4Q47588273-39723FE8-DB0D-4A13-A126-BF07C12CE811Q47836871-91B8A7EC-96F7-409D-AF77-30B0D3C21733Q49569343-F96FE741-C3DB-4171-B0A5-D558E816FD70Q51743312-F20890D7-0881-46B5-B8FF-FF48E3208109Q53685081-2BFAC3A2-2A8B-44BC-9C29-9478ABDA5351
P2860
New therapeutic avenues in ulcerative colitis: thinking out of the box.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
New therapeutic avenues in ulcerative colitis: thinking out of the box.
@en
type
label
New therapeutic avenues in ulcerative colitis: thinking out of the box.
@en
prefLabel
New therapeutic avenues in ulcerative colitis: thinking out of the box.
@en
P2860
P1433
P1476
New therapeutic avenues in ulcerative colitis: thinking out of the box.
@en
P2093
Joana Torres
Silvio Danese
P2860
P304
P356
10.1136/GUTJNL-2012-303959
P407
P577
2013-11-01T00:00:00Z